Axsome Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 685,125 | 1.41% |
| General Public | 987,255 | 2.04% |
| Hedge Funds | 4,189,557 | 8.64% |
| Private Companies | 7,344,500 | 15.2% |
| Institutions | 35,255,939 | 72.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 7,344,500 | US$731.9m | 0% | no data | |||
| 4,189,557 | US$417.5m | -9.6% | 5.43% | |||
| 3,995,345 | US$398.1m | 6.77% | 0.01% | |||
| 3,398,379 | US$338.6m | 2.98% | 0.01% | |||
| 2,360,077 | US$235.2m | 0% | 18.11% | |||
| 1,087,665 | US$108.4m | 20.6% | 0.01% | |||
| 1,046,000 | US$104.2m | 9.53% | 2.91% | |||
| 1,000,000 | US$99.7m | 0% | 1.13% | |||
| 995,287 | US$99.2m | -7.26% | 0.11% | |||
| 916,808 | US$91.4m | -2.31% | no data | |||
| 908,459 | US$90.5m | 2.66% | 0.01% | |||
| 857,219 | US$85.4m | -53.7% | 2.44% | |||
| 827,887 | US$82.5m | -11.8% | 1.32% | |||
| 782,844 | US$78.0m | 70.5% | 1.6% | |||
| 742,745 | US$74.0m | 1.11% | 0.01% | |||
| 738,503 | US$73.6m | -0.32% | 51.82% | |||
| 625,084 | US$62.3m | 13.8% | 0.85% | |||
| 602,024 | US$60.0m | -21.8% | 0.02% | |||
| 581,557 | US$58.0m | 4.68% | 0.01% | |||
| 577,190 | US$57.5m | 13.1% | 0.14% | |||
| 525,000 | US$52.3m | -28.1% | 0.09% | |||
| 467,427 | US$46.6m | 0% | 2.81% | |||
| 451,866 | US$45.0m | 2,990% | no data | |||
| 404,217 | US$40.3m | 0% | no data | |||
| 400,000 | US$39.9m | 0% | 2.36% |